scispace - formally typeset
T

Timothy T. Harkins

Researcher at Life Technologies

Publications -  82
Citations -  15373

Timothy T. Harkins is an academic researcher from Life Technologies. The author has contributed to research in topics: Genome & Deep sequencing. The author has an hindex of 43, co-authored 79 publications receiving 13693 citations. Previous affiliations of Timothy T. Harkins include Thermo Fisher Scientific & Roche Applied Science.

Papers
More filters
Journal ArticleDOI

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

Chetan Bettegowda, +69 more
TL;DR: The ability of circulating tumor DNA (ctDNA) to detect tumors in 640 patients with various cancer types was evaluated and suggested that ctDNA is a broadly applicable, sensitive, and specific biomarker that can be used for a variety of clinical and research purposes.
Journal ArticleDOI

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

TL;DR: It is shown that understanding the biology and therapeutic responses of patients with TNBC will require the determination of individual tumour clonal genotypes, and for the first time in an epithelial tumour subtype, the relative abundance of clonal frequencies among cases representative of the population is determined.
Journal ArticleDOI

Paired-end mapping reveals extensive structural variation in the human genome.

TL;DR: High-throughput and massive paired-end mapping (PEM) was used to map SVs in an African and in a putatively European individual and identified shared and divergent SVs relative to the reference genome, documenting that the number of SVs among humans is much larger than initially hypothesized; many of the SVs potentially affect gene function.
Journal ArticleDOI

Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

TL;DR: 25 spatially distinct regions from seven operable NSCLCs were sequenced and found evidence of branched evolution, with driver mutations arising before and after subclonal diversification, and pronounced intratumor heterogeneity in copy number alterations, translocations, and mutations associated with APOBEC cytidine deaminase activity.